Dimensional Fund Advisors’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
Dimensional Fund Advisors's PRAX Position: Q3 2026 in Review
Dimensional Fund Advisors increased its Praxis Precision Medicines (PRAX) stake by 13% in Q3 2026, buying an estimated $1.41M and bringing the position to 35,835 shares worth $10.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2254.
Dimensional Fund Advisors first reported a position in PRAX in Q3 2022 and has held it in 14 quarters since. The position peaked at $10.6M in Q2 2026. 86 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- Dimensional Fund Advisors held 35,835 shares of Praxis Precision Medicines worth $10.4M as of Q3 2026.
- Dimensional Fund Advisors bought 4,261 Praxis Precision Medicines shares in Q3 2026, an estimated $1.41M.
- Praxis Precision Medicines made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2254 holding.
- Dimensional Fund Advisors first reported a position in Praxis Precision Medicines in Q3 2022 and has held it in 14 quarters since.
- Dimensional Fund Advisors's Praxis Precision Medicines position peaked at $10.6M in Q2 2026.
- 86 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.